Dynamic Medical Technologies Inc. (TPEX:4138)
61.00
+0.10 (0.16%)
At close: Mar 27, 2026
TPEX:4138 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 152.06 | 205.39 | 210.32 | 137.11 | 123.21 |
Depreciation & Amortization | 148.68 | 177.05 | 148.51 | 115.2 | 95.94 |
Other Amortization | 0.82 | 0.73 | 0.45 | 0.2 | 0.25 |
Loss (Gain) From Sale of Assets | - | -0.7 | - | - | - |
Loss (Gain) on Equity Investments | 1.44 | -1.05 | -1.05 | 2.6 | -0.86 |
Stock-Based Compensation | - | 0.59 | - | - | - |
Provision & Write-off of Bad Debts | -4.38 | 0.85 | -2.94 | -2.84 | 1.27 |
Other Operating Activities | -0.98 | -8.79 | 40.39 | 22.42 | 25.01 |
Change in Accounts Receivable | -8.2 | -56.68 | -27.41 | -28.63 | 9.25 |
Change in Inventory | -53.85 | -7.26 | -73.58 | -102.49 | -52.46 |
Change in Accounts Payable | 10.57 | 21.15 | -37.86 | 2.49 | 34.46 |
Change in Unearned Revenue | 35.61 | -72.33 | 78.09 | 105.82 | 68.75 |
Change in Other Net Operating Assets | 33.07 | -34.85 | 26.02 | 25.05 | -27.17 |
Operating Cash Flow | 314.86 | 224.11 | 360.95 | 276.93 | 277.65 |
Operating Cash Flow Growth | 40.49% | -37.91% | 30.34% | -0.26% | 11.71% |
Capital Expenditures | -51.8 | -97.18 | -70.52 | -114.05 | -42.28 |
Sale of Property, Plant & Equipment | - | 0.91 | - | - | - |
Sale (Purchase) of Intangibles | -0.35 | -0.41 | -1.28 | -0.54 | -0.03 |
Investment in Securities | 74.48 | 40.97 | 49.71 | -134.37 | -44.74 |
Other Investing Activities | -70.21 | -5.89 | -6.6 | -2.33 | -5.37 |
Investing Cash Flow | -47.88 | -61.59 | -28.69 | -251.28 | -92.42 |
Short-Term Debt Issued | - | - | 100 | - | - |
Total Debt Issued | - | - | 100 | - | - |
Short-Term Debt Repaid | - | -100 | - | - | - |
Long-Term Debt Repaid | -85.53 | -74.01 | -61.13 | -50.28 | -39.96 |
Total Debt Repaid | -85.53 | -174.01 | -61.13 | -50.28 | -39.96 |
Net Debt Issued (Repaid) | -85.53 | -174.01 | 38.87 | -50.28 | -39.96 |
Common Dividends Paid | -150.65 | -222.75 | -94.5 | -111 | -105 |
Other Financing Activities | -32.25 | 17.76 | -29.77 | -25.59 | -3.72 |
Financing Cash Flow | -268.42 | -379.01 | -85.4 | -186.86 | -148.68 |
Foreign Exchange Rate Adjustments | -2.1 | 17.83 | -1.05 | 26.97 | -8.08 |
Net Cash Flow | -3.55 | -198.66 | 245.81 | -134.25 | 28.47 |
Free Cash Flow | 263.06 | 126.94 | 290.43 | 162.88 | 235.37 |
Free Cash Flow Growth | 107.23% | -56.29% | 78.31% | -30.80% | -2.08% |
Free Cash Flow Margin | 18.97% | 8.07% | 18.23% | 12.61% | 22.89% |
Free Cash Flow Per Share | 6.56 | 3.17 | 7.25 | 4.06 | 5.87 |
Cash Interest Paid | 4.82 | 5.62 | 2.3 | 1.33 | 0.87 |
Cash Income Tax Paid | 47.26 | 84.59 | 42.89 | 15.8 | 21.86 |
Levered Free Cash Flow | 199.09 | 74.04 | 281.57 | 165.68 | 219.93 |
Unlevered Free Cash Flow | 199.09 | 75.14 | 281.67 | 166.5 | 220.47 |
Change in Working Capital | 17.21 | -149.96 | -34.74 | 2.23 | 32.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.